Lower riskDrug recall · FDA · Published October 1, 2019
Sato Pharmaceutical Recalls Botanical Laxative Tablets Due to Subpotent Sennosides
Sato Pharmaceutical recalls 150-count laxative tablets with less than labeled sennosides. This may not provide expected bowel movement relief. Consumers should check lot numbers and contact the company for details.
“Sato Pharmaceutical Recalls Botanical Laxative Tablets Due to Subpotent Sennosides.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37874-sato-pharmaceutical-recalls-botanical-laxative-tablets-due-to-subpotent-sennosides. Based on FDA recall #D-0303-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0303-2020%22&limit=1).
The FDA announced on 2019-10-01 that Sato Pharmaceutical Inc. voluntarily recalled Sankaijo BOTANICAL LAXATIVE tablets due to subpotent drug risks, according to the FDA.
Distribution: Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
The hazard
The formulated amount of the sennosides component is less than the labeled claim, according to the FDA.
Context
GovInfoNow's records show Sato Pharmaceutical Inc. has 3 other recalls on record since 2017-02-16. Other recent recalls of similar products include Yunker Energy & Health Herbal Supplement with Vitamins Recall (2026-03-12), Sato Pharmaceutical Zentrip 25mg Strips Recall (2019-10-01), and Sato Pharmaceutical Inc. recalls SATO CLEAR Redness Reliever Eye Drops (2017-02-16). Additional similar product recalls include Sato Pharmaceutical INON ACE Antacid Tablets Recall (2025-12-19), Shoolin Pharma Chem Sildenafil Recall (2026-08-03), and Unichem busPIRone 5mg Tablets Recall (2026-04-13).
How to tell if you have this one
Check for lot numbers TXWT (expires Jan 2020), TXTS (expires Oct 2020), or AXWS (expires Oct 2021) on the packaging. The product is sold in 150-count bottles by Sato Pharmaceutical.
Brand
Sato Pharmaceutical
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Lot Number
Look for lot numbers TXWT, TXTS, or AXWS on the packaging to identify recalled items.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA and Guam and Saipan, Northern Mariana Islands” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0303-2020 (October 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0303-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.